A pharmaceutical company is currently appealing a record USD1.6 billion judgment in the US, arguing that a key part of the US False Claims Act (FCA) is unconstitutional. This case, now before the Court of Appeals for the...more
7/30/2025
/ Appeals ,
Constitutional Challenges ,
Enforcement Actions ,
False Claims Act (FCA) ,
Government Agencies ,
Healthcare Fraud ,
Medicare ,
Pharmaceutical Industry ,
SCOTUS ,
United States ex rel Polansky v Executive Health Resources Inc ,
Whistleblower Protection Policies ,
Whistleblowers
A new U.S. DOJ memo published on May 12 announces significant changes to the DOJ’s white-collar crime enforcement priorities, aligning the DOJ’s approach with the Trump Administration’s “America First” agenda. ...more
The U.S. Commodity Futures Trading Commission’s (CFTC) Whistleblower Office took the unusual step of inviting market participants to look for and submit tips related to fraud, manipulation, and other forms of misconduct in...more